Drug Profile
BMS 181448
Alternative Names: LumenHanceLatest Information Update: 03 Jun 2015
Price :
$50
*
At a glance
- Originator ImaRx Therapeutics
- Class Acetates; Amino acids; Biopolymers; Contrast media; Disaccharides; Inorganic chemicals
- Mechanism of Action Magnetic resonance imaging enhancers
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Marketed Gastrointestinal disorders